Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant
- PMID: 20096013
- DOI: 10.1111/j.1365-2141.2009.08072.x
Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant
Abstract
Patients aged 0-18 years with confirmed or possible invasive fungal infection were identified by medical record and database searches. Cases with an underlying diagnosis of acute leukaemia or following stem cell transplantation were included in a case control study. Controls included all other children with acute leukaemia or stem cell transplant in the corresponding time period. Variables collected included demographics, underlying disease risk and status, organ impairment, admission to intensive care unit, fungal infection details and certain transplant variables. Risk factors for development of invasive fungal infection were examined using logistic regression. There were 106 cases of invasive fungal infection during the study. The incidence of invasive fungal infection was 21% in acute lymphoblastic leukaemia, 15% in acute myeloid leukaemia and 25% following stem cell transplantation. Sixty per cent were neutropenic at diagnosis and 39% had concomitant bacteremia. High risk acute lymphoblastic leukaemia, relapsed disease, intensive care admission and graft-versus-host disease were significantly associated with development of invasive fungal infection on multivariate analysis. These associations provide new information on paediatric invasive fungal infections and warrant further study; caution should be encouraged when extrapolating from adult studies.
Similar articles
-
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.Clin Infect Dis. 2010 Apr 15;50(8):1091-100. doi: 10.1086/651263. Clin Infect Dis. 2010. PMID: 20218877
-
[Risk factors for invasive fungal infections during intensive chemotherapy of acute leukemia--retrospective study].Acta Med Croatica. 2004;58(4):275-84. Acta Med Croatica. 2004. PMID: 15700683 Croatian.
-
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.Bone Marrow Transplant. 1990 Jun;5(6):413-8. Bone Marrow Transplant. 1990. PMID: 2164434
-
Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S119-23. doi: 10.1016/S0924-8579(08)70012-8. Int J Antimicrob Agents. 2008. PMID: 19013335 Review.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
Incidence and Outcome of Invasive Fungal Diseases in Children With Hematological Malignancies and/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study.Front Microbiol. 2019 Apr 16;10:681. doi: 10.3389/fmicb.2019.00681. eCollection 2019. Front Microbiol. 2019. PMID: 31040830 Free PMC article.
-
Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S12-S21. doi: 10.1093/jpids/pix053. J Pediatric Infect Dis Soc. 2017. PMID: 28927201 Free PMC article. Review.
-
Fungal infections in children with haematologic malignancies and stem cell transplant recipients.Br J Haematol. 2020 May;189(4):607-624. doi: 10.1111/bjh.16452. Epub 2020 Mar 11. Br J Haematol. 2020. PMID: 32159231 Free PMC article. Review.
-
Current evidence of antifungal prophylaxis and therapy in pediatric patients.Pediatr Rep. 2011 Feb 24;3(1):e6. doi: 10.4081/pr.2011.e6. Pediatr Rep. 2011. PMID: 21647279 Free PMC article.
-
A Retrospective Analysis of Micafungin Prophylaxis in Children Under 12 Years Undergoing Chemotherapy or Hematopoietic Stem Cell Transplantation.J Pediatr Pharmacol Ther. 2024 Aug;29(4):379-384. doi: 10.5863/1551-6776-29.4.379. Epub 2024 Aug 13. J Pediatr Pharmacol Ther. 2024. PMID: 39144392 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical